MatthewHBuiMDPhD
Urology • Los Angeles, CAMinimally Invasive Surgery, Stone Disease, Surgical Oncology
Assistant Professor of Urology, Mayo Clinic College of Medicine
Dr. Bui is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8635 W 3rd St
Ste 1
Los Angeles, CA 90048Phone+1 310-854-9898Fax+1 310-854-1994
Summary
- Dr. Matthew Bui is an urologist in Los Angeles, CA and is affiliated with Cedars-Sinai Medical Center. He received his medical degree from Yale University School of Medicine and has been in practice 19 years. He also speaks multiple languages, including Vietnamese and Spanish. He specializes in minimally invasive surgery, stone disease, and surgical oncology and is experienced in prostate cancer, urinary incontinence, prostatitis, gonadotropin deficiency, and laparoscopy.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2004 - 2005- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1998 - 2004
Yale University School of MedicinePhD, Cell Biology, 1990 - 1998
Yale School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 2000 - 2026
AZ State Medical License 2005 - 2008- American Board of Urology Urology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Intergy EHR, Greenway Health, LLC, 2011
Publications & Presentations
PubMed
- 507 citationsCarbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: Implications for prognosis and therapyMatthew H. T. Bui, David Seligson, Ken Ryu Han, Allan J. Pantuck, Frederick J. Dorey
Clinical Cancer Research. 2003-02-01 - 135 citationsScoring algorithm to predict survival after nephrectomy and immunotherapy in patients with metastatic renal cell carcinoma: a stratification tool for prospective clini...Bradley C. Leibovich, Ken-ryu Han, Matthew H. T. Bui, Allan J. Pantuck, Frederick J. Dorey
Cancer. 2003-12-15 - 170 citationsUSING TUMOR MARKERS TO PREDICT THE SURVIVAL OF PATIENTS WITH METASTATIC RENAL CELL CARCINOMAHyung L. Kim, David Seligson, Xueli Liu, Nicolette Janzen, Matthew H. T. Bui
The Journal of Urology. 2005-05-01
Professional Memberships
- Member
- Los Angeles County Medical AssociationMember
Other Languages
- Vietnamese, Spanish
External Links
- Matthew Buihttp://drmatthewbui.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
